Literature DB >> 11016451

Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans.

V Gmyr1, J Kerr-Conte, S Belaich, B Vandewalle, E Leteurtre, M C Vantyghem, M Lecomte-Houcke, C Proye, J Lefebvre, F Pattou.   

Abstract

Human pancreatic cells with a typical ductal phenotype and potential to proliferate can be obtained in vitro, but the differentiation capacity of these putative human pancreatic stem cells remains to be documented. We investigated the protein and mRNA expression of insulin promoter factor 1 (IPF-1) (or pancreas/duodenal homeobox 1), a transcription factor critical for pancreatic development and endocrine cell neogenesis, in human pancreatic ductal cells derived from cultured exocrine tissue. In vitro, exocrine cells rapidly adhered (within 12 h) and were de-/transdifferentiated to ductal cells after 3 days with a dramatic loss of amylase protein (n = 4, 92 +/- 3.3%, P < 0.05 vs. day 1) and a simultaneous increase of ductal cytokeratin 19 protein (n = 4, 3.4-fold on day 3 and 7-fold on day 9, P < 0.05 vs. day 1). IPF-1 protein and mRNA levels were low to undetectable in exocrine preparations before culture. After 2 days of culture, a 3.2-fold increase in IPF-1 protein was observed, corresponding to the characteristic 46-kDa protein in Western blots. Reverse transcriptase-polymerase chain reaction confirmed a 10.5-fold increase in IPF-1 mRNA levels after 3 days of culture (n = 5, P < 0.001 vs. day 1). Double immunocytochemistry showed direct evidence that IPF-1 appeared during culture in these exocrine-derived ductal cells (cytokeratin 7-positive) and was not merely in contaminating endocrine cells (chromogranin A-positive). In conclusion, we describe herein the first converging evidence on both the molecular and protein level that human cells with a typical ductal phenotype derived ex vivo from pancreatic exocrine tissue (obtained from healthy donors) can reexpress IPF-1 in culture, suggesting their pancreatic precursor/stem cell potential.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016451     DOI: 10.2337/diabetes.49.10.1671

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Developmental aspects of the endocrine pancreas.

Authors:  Daniel M Kemp; Melissa K Thomas; Joel F Habener
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Neurogenin3 triggers beta-cell differentiation of retinoic acid-derived endoderm cells.

Authors:  Amedeo Vetere; Eleonora Marsich; Matteo Di Piazza; Raffaella Koncan; Fulvio Micali; Sergio Paoletti
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

3.  Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells.

Authors:  Marjorie Fanjul; Valéry Gmyr; Coralie Sengenès; Ginette Ratovo; Marlène Dufresne; Bruno Lefebvre; Julie Kerr-Conte; Etienne Hollande
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

4.  Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells.

Authors:  Kohtaro Minami; Masaaki Okuno; Kazumasa Miyawaki; Akinori Okumachi; Katsuhiko Ishizaki; Kazunobu Oyama; Miho Kawaguchi; Nobuko Ishizuka; Toshihiko Iwanaga; Susumu Seino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-06       Impact factor: 11.205

5.  Stimulation of cAMP signalling allows isolation of clonal pancreatic precursor cells from adult mouse pancreas.

Authors:  T Yamamoto; E Yamato; H Taniguchi; M Shimoda; F Tashiro; M Hosoi; T Sato; S Fujii; J-I Miyazaki
Journal:  Diabetologia       Date:  2006-08-08       Impact factor: 10.122

Review 6.  Alternatives to unmodified human islets for transplantation.

Authors:  Alberto Hayek; Gillian M Beattie
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

7.  Proliferation of sorted human and rat beta cells.

Authors:  G Parnaud; D Bosco; T Berney; F Pattou; J Kerr-Conte; M Y Donath; C Bruun; T Mandrup-Poulsen; N Billestrup; P A Halban
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

8.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

9.  Tissue-derived stem and progenitor cells.

Authors:  Leora J Tesche; David A Gerber
Journal:  Stem Cells Int       Date:  2009-10-28       Impact factor: 5.443

Review 10.  Slow and steady is the key to beta-cell replication.

Authors:  Kristen Brennand; Doug Melton
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.